Hims & Hers Health, Inc. (HIMS) stock analysis
Healthcare · Drug Manufacturers - Specialty & Generic
From the 10-K filed 2026-02-23
How it makes money
Recurring subscriptions for chronic conditions drive revenue, with the majority of prescriptions fulfilled through its wholly-owned pharmacies to capture full margin.
The business model centers on chronic conditions like hair loss and sexual health that require long-term, recurring medication. It connects patients to clinicians through its digital platform and then processes the resulting prescriptions internally.
By fulfilling the majority of these prescriptions through its own cloud-enabled pharmacies rather than third-party retail networks, it captures the full fulfillment margin while maintaining control over the speed and quality of the customer experience.
What protects it: the moat
It integrates a proprietary electronic medical record system with a distributed provider network to create a personalized clinical experience that limits customer churn.
The company has built a custom technology stack that links clinical provider consultations directly to its electronic medical records and cloud pharmacy fulfillment system.
This infrastructure allows for personalized compounded medications and tailored treatment plans. Management claims this clinical integration, supported by evidence-based guidelines and a medical advisory board, establishes consumer trust that generic retailers find difficult to replicate.
What growth costs
It is expanding internationally through a $1.15 billion acquisition of Eucalyptus to enter markets in Australia and Japan.
Growth requires heavy capital allocation for geographic expansion. The eucalyptus acquisition involves $240 million in upfront cash, with an additional $710 million in deferred payments over 18 months.
Beyond acquisitions, the business must reinvest in product research and development to create new formulations with manufacturers and expand its clinical offerings into categories like weight loss and hormone health.
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. The company was formerly known as Hims, Inc. and changed its name to Hims & Hers Health, Inc. in January 2021. The company was founded in 2017 and is based in San Francisco, California.